Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
NEW TAIPEI CITY, Taiwan, Nov. 28, 2022 /PRNewswire/ -- Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrated full function service group. The newly formed Medeologix family of companies, with a combined footprint of 90,000 sq.ft, offers one-stop services from conceptual design to high-volume production.
The three Silicon Valley companies, Mediballoon, MedeonBio and Second Source Medical, along with Medeologix with a mass production facility in Taiwan, form the vertically integrated services from medical tubing extrusion, balloon forming, catheter processing, final assembly to packaging and logistic services. Together, they work seamlessly to support their clients from concepts to quality finished medical products for the MedTech industry.
MediBalloon, established in 2016, is an expert in extruding medical tubing and developing medical balloons in different shapes and sizes using various thermoplastic materials including Polyurethane, Polyethylene, Polyvinylidene fluoride (PVDF), Polybutylene terephthalate (PBT), Polyethylene terephthalate (PET), PEBAX, and Nylons. The customer base includes startups and major OEM giants who seek fast turn-around time for their standard and complex balloon designs and catheter tubing.
MedeonBio, established in 2012, specializes in single and multi-lumen catheter processes, including braiding, coil winding, lamination, thermal fusing, tipping, balloon bonding and pleating, as well as hydrophilic coating. These catheters are commonly used in minimally invasive procedures for cardiovascular, neurovascular, peripheral and structural heart diseases.
Second Source Medical, established in 2004, is an FDA registered contract manufacturer with full FDA QSR and cGMP compliant for Class II and Class III PMA products, providing rapid response of integrated design and manufacturing services from component, functional prototype, subassembly, process development, verification and va
Exciting News! Our Taiwan Mass Production Center Completed Successful ISO 13485:2016 Audit in October 2022.
Medeologix is proud to announce that its mass production center in Taiwan has recently passed the ISO13485:2016 audit. Along with our Bay Area family of companies, we can offer complete one-stop service for advanced balloon and catheter technologies for startups and large clients to take your projects from napkin to prototype and commercialization.